Your browser doesn't support javascript.
loading
The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis.
Cui, Saijin; Zhang, Yaling; Liu, Lu; Li, Yan; Zhou, Rongmiao; Huang, Xi; Cao, Shiru; Huo, Xiangran; Wang, Na.
Afiliación
  • Cui S; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang Y; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu L; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li Y; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhou R; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Huang X; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Cao S; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Huo X; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang N; Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. hbykdxwn@163.com.
Ann Palliat Med ; 10(2): 1851-1860, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33474947
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Systematic_reviews Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Systematic_reviews Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article